Back to search

Article

Geographic variation in dementia-related adverse events associated with sacubitril/valsartan: Analysis of the FDA Adverse Event Reporting System

2023-10-31

Abstract excerpt

<title>Abstract</title> <p>This study aimed to investigate geographical variation in the risk of dementia-related adverse events (AEs) associated with sacubitril/valsartan. Cases from the FDA Adverse Event Reporting System involving patients aged 60 or older with sacubitril/valsartan or angiotensin receptor blockers (ARBs) were analyzed. The reporting odds ratios (RORs) for dementia-related AEs were calculated fo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d761548f-f0b7-5739-baba-f1f652ed7a50
DOI
10.21203/rs.3.rs-3482453/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Geographic variation in dementia-related adverse events associated with sacubitril/valsartan: Analysis of the FDA Adverse Event Reporting SystemDOI 10.21203/rs.3.rs-3482453/v1
Select a neighboring publication to make it the new centre.